Frovatriptan clinical trials
Also written Frova.
How each study uses frovatriptan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 8 Nov 2001 · FROVA · NDA 021006 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 4
Endo Pharmaceuticals (3) · University of Calgary (1) · SK Chemicals Co., Ltd. (1) · Clinvest (1) · Scott and White Hospital & Clinic (1) · Thomas Jefferson University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses frovatriptan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedPhase 3Endo PharmaceuticalsNCT01035983Written as Frovatriptan 2.5 mg
- A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual MigraineCompletedPhase 3Endo PharmaceuticalsNCT00644033Written as Frovatriptan
- Frovatriptan as a Transitional Therapy in Medication Overuse HeadacheCompletedPhase 2University of CalgaryNCT01044251Written as Frovatriptan
- A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of MigraineCompletedPhase 3SK Chemicals Co., Ltd.NCT00821483Written as Frovatriptan
- Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of MigraineCompletedPhase 4ClinvestNCT00846495Written as frovatriptan
- Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free IntervalsCompletedNot applicableScott and White Hospital & ClinicNCT00700128Written as frovatriptan
- A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After FastingCompletedNot applicableThomas Jefferson UniversityNCT00440232Written as Frovatriptan
- Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual MigraineCompletedPhase 4Endo PharmaceuticalsNCT00904098Written as Frovatriptan
Codes
What other systems call frovatriptan · ClinicalTrials.gg INT004016
- MeSH (NLM) C108128frovatriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) H82Q2D5WA7FROVATRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 228783Confirmed FDA, Wikidata
- Wikidata Q410195frovatriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65772FrovatriptanOne source FDA
- DrugBank DB00998One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C108128 | frovatriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | H82Q2D5WA7 | FROVATRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 228783 | — | Confirmed FDA, Wikidata |
| Wikidata | Q410195 | frovatriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65772 | Frovatriptan | One source FDA |
| DrugBank | DB00998 | — | One source Wikidata |
Also registered as frovatriptan succinate (UNII D28J6W18HY · RxNorm 322249).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.